Regenerative Medicine News
Neuralstem Approved To Commence Ischemic Stroke Trial In China
Sept. 27, 2012 - (NeuralStem) - "Neuralstem, Inc. announced it has been approved to commence a clinical trial to treat motor deficits due to ischemic stroke with its spinal cord stem cells (NSI-566) at BaYi Brain Hospital, in Beijing, China, through its subsidiary, Neuralstem China (Suzhou Neuralstem Biopharmaceutical Company, Ltd.)." Read Full Article
Posted on
8-Oct-12
by Gallerno, Jacob
Tags:
Science and Industry News
Trackback Url
|
Link to this post
| Bookmark this post with:
